Trieu-my Van

Koeln, NW 50931, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Corrigendum to Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis.

Corrigendum to Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis.

Journal: The Journal of clinical investigation

Published: December 01, 2025

Smooth muscle cell specific NEMO deficiency inhibits atherosclerosis in ApoE-/- mice.

Smooth muscle cell specific NEMO deficiency inhibits atherosclerosis in ApoE-/- mice.

Journal: Scientific reports

Published: May 23, 2022

NF-κB inhibition in keratinocytes causes RIPK1-mediated necroptosis and skin inflammation.

NF-κB inhibition in keratinocytes causes RIPK1-mediated necroptosis and skin inflammation.

Journal: Life science alliance

Published: November 13, 2020

Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis.

Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis.

Journal: The Journal of clinical investigation

Published: December 28, 2016

RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.

RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.

Journal: Nature

Published: June 13, 2016

NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.

NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.

Journal: Cancer cell

Published: December 14, 2015

Dicer1-miR-328-Bace1 signalling controls brown adipose tissue differentiation and function.

Dicer1-miR-328-Bace1 signalling controls brown adipose tissue differentiation and function.

Journal: Nature cell biology

Published: October 04, 2015

Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo.

Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: July 13, 2014

NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.

NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.

Journal: Cancer cell

Published: March 24, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026